Argenica Therapeutics Limited (ASX:AGN)

Argenica Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Cash & Equivalents	6.36	10.56	15.91	9.29	8.91
Short-Term Investments	-	-	-	0.05	-
Cash & Short-Term Investments	6.36	10.56	15.91	9.34	8.91
Cash Growth	-39.72%	-33.67%	70.39%	4.76%	24.78%
Accounts Receivable	0.1	-	-	-	-
Other Receivables	-	0.42	0.37	0.15	0.07
Receivables	0.1	0.42	0.37	0.15	0.07
Prepaid Expenses	-	0.06	0.09	0.05	0.06
Other Current Assets	0.06	-	-	-	-
Total Current Assets	6.52	11.04	16.38	9.54	9.04
Other Intangible Assets	0	0	0	0	0
Total Assets	6.52	11.04	16.38	9.54	9.04

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Accounts Payable	0.54	2.88	1.4	1.14	0.67
Accrued Expenses	0.08	0.27	0.3	0.05	0.05
Current Unearned Revenue	-	0.62	0.7	0.66	-
Other Current Liabilities	-	0.03	0.02	0.02	0.02
Total Current Liabilities	0.61	3.8	2.43	1.87	0.74
Total Liabilities	0.61	3.8	2.43	1.87	0.74

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Common Stock	29.82	29.63	28.43	16.62	13.07
Retained Earnings	-24.1	-22.73	-15.69	-10.32	-5.5
Comprehensive Income & Other	0.18	0.34	1.21	1.37	0.75
Shareholders' Equity	5.9	7.24	13.95	7.67	8.31
Total Liabilities & Equity	6.52	11.04	16.38	9.54	9.04

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Net Cash (Debt)	6.36	10.56	15.91	9.34	8.91
Net Cash Growth	-39.72%	-33.67%	70.39%	4.76%	24.78%
Net Cash Per Share	0.05	0.08	0.15	0.13	0.12
Filing Date Shares Outstanding	119.73	128.46	127.13	99.15	86.92
Total Common Shares Outstanding	119.73	128.45	123.7	98.35	86.92
Working Capital	5.9	7.24	13.95	7.67	8.31
Book Value Per Share	0.05	0.06	0.11	0.08	0.10
Tangible Book Value	5.9	7.24	13.95	7.67	8.31
Tangible Book Value Per Share	0.05	0.06	0.11	0.08	0.10

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 26, 2026

Data Sources Report a data error